Research ExplorerPublicationsPrevalence of key resistance mutations K65R, K103N, and M184...

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.

Standard

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. / Metzner, Karin J; Rauch, Pia; Braun, Patrick; Knechten, Heribert; Ehret, Robert; Korn, Klaus; Kaiser, Rolf; Sichtig, Nadine; Ranneberg, Britta; van Lunzen, Jan; Walter, Hauke.

In: J CLIN VIROL, Vol. 50, No. 2, 2, 2011, p. 156-161.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Metzner, KJ, Rauch, P, Braun, P, Knechten, H, Ehret, R, Korn, K, Kaiser, R, Sichtig, N, Ranneberg, B, van Lunzen, J & Walter, H 2011, 'Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.', J CLIN VIROL, vol. 50, no. 2, 2, pp. 156-161. <http://www.ncbi.nlm.nih.gov/pubmed/21056001?dopt=Citation>

APA

Metzner, K. J., Rauch, P., Braun, P., Knechten, H., Ehret, R., Korn, K., Kaiser, R., Sichtig, N., Ranneberg, B., van Lunzen, J., & Walter, H. (2011). Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. J CLIN VIROL, 50(2), 156-161. [2]. http://www.ncbi.nlm.nih.gov/pubmed/21056001?dopt=Citation

Vancouver

Metzner KJ, Rauch P, Braun P, Knechten H, Ehret R, Korn K et al. Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. J CLIN VIROL. 2011;50(2):156-161. 2.

Bibtex

@article{e90b095aa8a9434ca31a1d91405ca70e,
title = "Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-na{\"i}ve patients.",
abstract = "Minority drug-resistant HIV-1 variants, undetected by conventional genotyping, may impair the outcome of antiretroviral therapy (ART). Thus, we retrospectively analyzed the prevalence of minority drug-resistant HIV-1 variants before ART in chronically HIV-1 infected patients initiating first-line therapy and assessed the impact on clinical outcome in the prospective German Truvada cohort.",
author = "Metzner, {Karin J} and Pia Rauch and Patrick Braun and Heribert Knechten and Robert Ehret and Klaus Korn and Rolf Kaiser and Nadine Sichtig and Britta Ranneberg and {van Lunzen}, Jan and Hauke Walter",
year = "2011",
language = "Deutsch",
volume = "50",
pages = "156--161",
journal = "J CLIN VIROL",
issn = "1386-6532",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients.

AU - Metzner, Karin J

AU - Rauch, Pia

AU - Braun, Patrick

AU - Knechten, Heribert

AU - Ehret, Robert

AU - Korn, Klaus

AU - Kaiser, Rolf

AU - Sichtig, Nadine

AU - Ranneberg, Britta

AU - van Lunzen, Jan

AU - Walter, Hauke

PY - 2011

Y1 - 2011

N2 - Minority drug-resistant HIV-1 variants, undetected by conventional genotyping, may impair the outcome of antiretroviral therapy (ART). Thus, we retrospectively analyzed the prevalence of minority drug-resistant HIV-1 variants before ART in chronically HIV-1 infected patients initiating first-line therapy and assessed the impact on clinical outcome in the prospective German Truvada cohort.

AB - Minority drug-resistant HIV-1 variants, undetected by conventional genotyping, may impair the outcome of antiretroviral therapy (ART). Thus, we retrospectively analyzed the prevalence of minority drug-resistant HIV-1 variants before ART in chronically HIV-1 infected patients initiating first-line therapy and assessed the impact on clinical outcome in the prospective German Truvada cohort.

M3 - SCORING: Zeitschriftenaufsatz

VL - 50

SP - 156

EP - 161

JO - J CLIN VIROL

JF - J CLIN VIROL

SN - 1386-6532

IS - 2

M1 - 2

ER -